Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-02-22 Hatfield Jeffrey S. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +275,000 275,000
2018-02-22 Hughes Thomas E. See Remarks Grant or award · Stock Option (right to buy) +275,000 275,000
2018-02-22 Allen Patricia L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2018-01-03 Daniel Thomas O Director Grant or award +8,687 $5.18 $45K 19,452
2018-01-03 LAMATTINA JOHN L Director Grant or award +9,169 $5.18 $47K 20,532
2018-01-03 Barrett Peter Director Grant or award · Stock Option (Right to Buy) +17,627 17,627
2018-01-03 Booth Bruce Director Grant or award · Stock Option (Right to Buy) +8,509 8,509
2018-01-03 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +9,725 9,725
2018-01-03 PEREZ ROBERT J Director Grant or award · Stock Option (Right to Buy) +9,421 9,421
2017-12-29 Hatfield Jeffrey S. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +1,100,000 1,100,000
2017-10-13 Heller Frances K Director Purchase +10,000 $3.90 $39K 47,961
2017-10-09 Hatfield Jeffrey S. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +550,000 550,000
2017-10-09 Hughes Thomas E. See Remarks Grant or award · Employee Stock Option (right to buy) +275,000 275,000
2017-07-11 KIM DENNIS D Chief Medical Officer Purchase +10,000 $3.39 $34K 21,443
2017-06-21 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 Booth Bruce Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 LAMATTINA JOHN L Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 THOMAS FRANK E Director Grant or award · Stock Option (Right to Buy) +14,500 14,500
2017-06-21 Barrett Peter Director Grant or award · Stock Option (Right to Buy) +14,500 14,500

Page 9 of 15 · 296 trades